Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients

Zimmer Biomet

Status: Completed

Conditions: Osteoarthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT01050894

APS-001

Details and patient eligibility

About

This is a feasibility study to determine if anti-inflammatory cytokines can be concentrated from patients with osteoarthritis.

Enrollment: 105 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• radiographic evidence of osteoarthritis
• signed informed consent

Exclusion criteria

• Pregnancy
• < 18 years of age
• blood clotting disorder or active hematologic cancer
• undergoing chemotherapy
• history of rheumatoid arthritis
• septic joint or fracture
• active infection or history of chronic infection
• use of cytokine blocking drugs with the last 6 months
• intra-articular steroid or hyaluronic acid (HA) injection within last 6 months

Trial design

105 participants in 1 patient group

osteoarthritis patients